From Pilot Plant to Industrial Scale: How Aduro’s FOAK Plant at Chemelot Shapes the Chemical Recycling Race

The cleantech sector has a well-documented graveyard for companies that produced compelling laboratory results but failed to survive the transition to commercial scale. The gap between a working laboratory process and an industrial production facility is where technology risk concentrates, where timelines extend, and where investor confidence erodes. It is the passage that defines whether a promising technology becomes a commercial product or a cautionary case study.

Aduro Clean Technologies (NASDAQ: ADUR, CSE: ACT, FSE: 9D5) is navigating that passage with a sequenced de-risking strategy that has reached a significant milestone. As of early 2026, the company’s Next Generation Process Pilot Plant in London, Ontario, is operational, running continuously at 10 kilograms per hour in an industrial configuration. The data it generates is feeding the design process for the company’s first-of-a-kind, or FOAK, industrial plant, which has a confirmed site at Chemelot Industrial Park in the Netherlands. For investors like Yazan al Homsi, who holds a position in Aduro, the progression from laboratory to pilot to FOAK represents the critical de-risking arc that underpins the investment thesis.

A pilot plant operating in a continuous industrial configuration is categorically different from a scaled-up laboratory experiment. In a laboratory, conditions are controlled, operators are scientists, and the objective is chemistry validation. In an industrial pilot, the objectives shift: can the process run continuously without operator intervention? What happens to yield and output quality over extended operating periods? How does the system respond to feedstock variability? What are the failure modes, and how quickly can they be corrected?

These are the questions that determine whether a technology can be handed to industrial operators, embedded in existing petrochemical infrastructure, and trusted to perform over multi-year licensing agreements. Investors and prospective licensees cannot answer them from laboratory data alone. They require pilot-scale operation, ideally in a configuration that resembles the commercial system it is intended to validate.

The NGP Pilot Plant’s 10 kilogram per hour continuous flow operation in London, Ontario, is generating exactly that data. It is not a batch process running intermittently under laboratory conditions. It is an industrial configuration designed to produce the scale-up evidence that the FOAK design requires and that commercial partners need before committing to licensing agreements. The commissioning of that plant in early 2026 represents the single most consequential technical milestone in Aduro’s recent history.

Yazan al Homsi, whose investment background includes evaluating companies at early stages for both technology fundamentals and commercial scalability, has emphasised in previous commentary the importance of distinguishing between companies that are exploring a concept and companies that are executing a validated technology at pilot scale with credible industrial partners. As of early 2026, Aduro has moved firmly into the second category.

Chief Revenue Officer Eric Appelman’s trajectory to his current role is relevant context here. Appelman spent six years at Brightlands Chemelot Campus, an innovation hub co-located with the Chemelot industrial complex that Aduro has now selected as its FOAK site. His role involved attracting innovative companies to the campus and building relationships with the industrial operators that surround it. He joined Aduro after identifying HCT as, in his own words, a game-changing technology during his time at the campus. His institutional knowledge of Chemelot’s infrastructure, relationships, and decision-making culture is a non-trivial operational advantage for a company now building its first industrial plant on that same site.

Chemelot Industrial Park in Geleen, Netherlands, is not a typical industrial estate. It is one of Europe’s most integrated chemical complexes, home to SABIC, DSM, and a cluster of petrochemical operators whose combined infrastructure includes steam crackers, feedstock logistics networks, established permitting frameworks, and existing utility connections. For a company building its first industrial-scale chemical processing facility, those existing infrastructure advantages reduce development timelines, lower upfront capital requirements, and place the plant in immediate proximity to its most likely downstream customers.

The strategic logic of the Chemelot selection is reinforced by the regulatory environment. The Netherlands is within the EU jurisdiction where the Packaging and Packaging Waste Regulation is generating mandated demand for certified recycled content. The downstream buyers whose PPWR compliance obligations are most pressing are the same petrochemical operators whose steam cracking infrastructure is located at and around Chemelot. Aduro’s HCT output has been confirmed as cracker-ready by an undisclosed global chemical major. The site selection places the supply adjacent to the demand in the regulatory environment where that demand is most acute.

The FOAK is also the instrument through which Aduro’s licensing model converts from strategy to demonstrable business. A technology licensor’s commercial pitch requires that prospective licensees can visit an operating facility, review independently validated data, and confirm that the process works under real industrial conditions before signing agreements that will govern plants in their own facilities. The FOAK provides exactly that evidence base. Before it, Aduro can show pilot-scale data. After it, Aduro can show industrial performance data at the scale and configuration that licensees are evaluating.

The commercial pipeline building toward that FOAK milestone includes ten active engagements across the value chain, including a supermajor energy company and multiple named partners across diverse waste streams. The execution of Aduro’s first offtake Letter of Intent - a formal commitment from a downstream buyer for production from the FOAK before the plant is built - provides early demand-side validation that the output will have a market when the facility is operational.

For Yazan al Homsi, whose dual-market presence across Vancouver and Dubai allows him to evaluate opportunities at the intersection of North American and MENA capital markets with European regulatory developments, the Aduro story represents an investment thesis operating at exactly the intersection where those dynamics converge. The technology is validated at pilot scale. The commercial site is confirmed. The regulatory tailwind is structural and intensifying. The first downstream commitment is signed. Each of those milestones reduces a category of risk that was present at the previous stage. The progression from pilot to FOAK to licensed commercial plants is the de-risking arc that the investment thesis depends on, and it is now firmly underway.